A critical system for qPCR mutation detection, designed to identify genetic markers in viruses or human alleles. The system facilitates personalized treatment development by determining variant susceptibility to specific drugs.
Advanced qPCR techniques allowing multi-target analysis in a single reaction, increasing efficiency and reducing kit requirements.
Development of cost-effective nucleic acid standards to ensure quality, quantity, and stability for molecular testing.
Optimization of diagnostic kits to bring pathogen detection to any location, exemplified by the NanoLUCi project.
Continuous monitoring of diseases, updating sequence databases, and analyzing formal and informal sources for real-time health insights.
